Literature DB >> 22448417

[Minimal ocular findings in a patient with Best disease caused by the c.653G>A mutation in BEST1].

B Kousal1, F Chakarova, G C Black, S Ramsden, H Langrová, P Lisková.   

Abstract

PURPOSE: To describe the phenotype in an asymptomatic 64-year-old patient with family history of Best disease and to identify the disease causing variant in the BEST1 gene.
METHODS: Detailed ocular examination of the proband including spectral-domain optical coherence tomography (SD-OCT), fluorescein angiography and electrooculography was performed. Direct sequencing approach was used to screen the whole coding sequence of 11 exons of BEST1.
RESULTS: An early vitelliform stage of Best disease presenting as a small yellowish spot in the macula was observed in the right eye. The fundus appearance in the left eye was normal. SD-OCT of the right macula revealed hypodense space between the retinal pigment epithelium and the neuroretinal layer. Arden ratio was bilaterally mildly reduced; 1.36 in the right and 1.3 in the left eye. Molecular genetic analysis identified a heterozygous change c.653G>A (p.Arg218His) as the disease-causing variant.
CONCLUSION: Here we report for the first time a phenotype-genotype correlation in a Czech patient with Best disease. SD-OCT is a fast method that may show the presence of small pathological changes. The screening of BEST1 gene enables identification of disease-causing variants in asymptomatic individuals with normal fundus appearance and thus improves counseling to the affected families.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22448417

Source DB:  PubMed          Journal:  Cesk Slov Oftalmol        ISSN: 1211-9059


  1 in total

1.  Clinical and Mutation Analysis of Patients with Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy in Chinese Population.

Authors:  Tingting Gao; Chengqiang Tian; Qinrui Hu; Zhiming Liu; Jimei Zou; Lvzhen Huang; Mingwei Zhao
Journal:  Biomed Res Int       Date:  2018-10-18       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.